
Xiaoming Liu
Examiner (ID: 709, Phone: (571)270-0384 , Office: P/2812 )
| Most Active Art Unit | 2812 |
| Art Unit(s) | 2812 |
| Total Applications | 629 |
| Issued Applications | 504 |
| Pending Applications | 79 |
| Abandoned Applications | 79 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8094065
[patent_doc_number] => 20120082636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-05
[patent_title] => 'STABILIZED ALPHA HELICAL PEPTIDES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/252751
[patent_app_country] => US
[patent_app_date] => 2011-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 18692
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20120082636.pdf
[firstpage_image] =>[orig_patent_app_number] => 13252751
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/252751 | Stabilized alpha helical peptides and uses thereof | Oct 3, 2011 | Issued |
Array
(
[id] => 8056035
[patent_doc_number] => 20120077749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'Biologically Active Peptides'
[patent_app_type] => utility
[patent_app_number] => 13/238751
[patent_app_country] => US
[patent_app_date] => 2011-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22363
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20120077749.pdf
[firstpage_image] =>[orig_patent_app_number] => 13238751
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/238751 | Procoagulant peptides | Sep 20, 2011 | Issued |
Array
(
[id] => 8172120
[patent_doc_number] => 20120107800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'CELL-TARGETING NANOPARTICLES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/236567
[patent_app_country] => US
[patent_app_date] => 2011-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5974
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20120107800.pdf
[firstpage_image] =>[orig_patent_app_number] => 13236567
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/236567 | Cell-targeting nanoparticles and uses thereof | Sep 18, 2011 | Issued |
Array
(
[id] => 8708534
[patent_doc_number] => 20130065823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'Supplement for Strengthening the Muscles of a Human'
[patent_app_type] => utility
[patent_app_number] => 13/232032
[patent_app_country] => US
[patent_app_date] => 2011-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1833
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13232032
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/232032 | Supplement for Strengthening the Muscles of a Human | Sep 13, 2011 | Abandoned |
Array
(
[id] => 10090183
[patent_doc_number] => 09126997
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-09-08
[patent_title] => 'Synergistic effect of glucocorticoid receptor agonists in combination with proteosome inhibitors for treating leukemia and myeloma'
[patent_app_type] => utility
[patent_app_number] => 13/226865
[patent_app_country] => US
[patent_app_date] => 2011-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5293
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13226865
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/226865 | Synergistic effect of glucocorticoid receptor agonists in combination with proteosome inhibitors for treating leukemia and myeloma | Sep 6, 2011 | Issued |
Array
(
[id] => 10155765
[patent_doc_number] => 09187523
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-17
[patent_title] => 'Substrate peptide sequences for plague plasminogen activator and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/199407
[patent_app_country] => US
[patent_app_date] => 2011-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 27
[patent_no_of_words] => 10266
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13199407
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/199407 | Substrate peptide sequences for plague plasminogen activator and uses thereof | Aug 28, 2011 | Issued |
Array
(
[id] => 8566095
[patent_doc_number] => 20120328666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-27
[patent_title] => 'ORAL DELIVERY OF PEPTIDE PHARMACEUTICAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/219132
[patent_app_country] => US
[patent_app_date] => 2011-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10509
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13219132
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/219132 | Oral delivery of peptide pharmaceutical compositions | Aug 25, 2011 | Issued |
Array
(
[id] => 7784675
[patent_doc_number] => 20120046231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-23
[patent_title] => 'COMPOSITION AND PROCESS FOR SYNTHESIZING POLYMERIZED HUMAN SERUM ALBUMIN FOR APPLICATIONS IN TRANSFUSION MEDICINE'
[patent_app_type] => utility
[patent_app_number] => 13/215473
[patent_app_country] => US
[patent_app_date] => 2011-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4977
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20120046231.pdf
[firstpage_image] =>[orig_patent_app_number] => 13215473
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/215473 | COMPOSITION AND PROCESS FOR SYNTHESIZING POLYMERIZED HUMAN SERUM ALBUMIN FOR APPLICATIONS IN TRANSFUSION MEDICINE | Aug 22, 2011 | Abandoned |
Array
(
[id] => 7651815
[patent_doc_number] => 20110301084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'Protracted Exendin-4 Compounds'
[patent_app_type] => utility
[patent_app_number] => 13/212439
[patent_app_country] => US
[patent_app_date] => 2011-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10431
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0301/20110301084.pdf
[firstpage_image] =>[orig_patent_app_number] => 13212439
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/212439 | Protracted exendin-4 compounds | Aug 17, 2011 | Issued |
Array
(
[id] => 8555191
[patent_doc_number] => 08329662
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-11
[patent_title] => 'Prodrug of an ICE inhibitor'
[patent_app_type] => utility
[patent_app_number] => 13/210712
[patent_app_country] => US
[patent_app_date] => 2011-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8036
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13210712
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/210712 | Prodrug of an ICE inhibitor | Aug 15, 2011 | Issued |
Array
(
[id] => 7568208
[patent_doc_number] => 20110288271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'AGENT DERIVED FROM TORTOISE SPLEEN STIMULATING MAMMALIAN HEMOPOIESIS'
[patent_app_type] => utility
[patent_app_number] => 13/195093
[patent_app_country] => US
[patent_app_date] => 2011-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 10131
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20110288271.pdf
[firstpage_image] =>[orig_patent_app_number] => 13195093
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/195093 | Agent derived from tortoise spleen stimulating mammalian hemopoiesis | Jul 31, 2011 | Issued |
Array
(
[id] => 8483057
[patent_doc_number] => 20120282464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => 'Spherical Protein Particles and Methods of Making and Using Them'
[patent_app_type] => utility
[patent_app_number] => 13/192345
[patent_app_country] => US
[patent_app_date] => 2011-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 30776
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13192345
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/192345 | Spherical Protein Particles and Methods of Making and Using Them | Jul 26, 2011 | Abandoned |
Array
(
[id] => 7501500
[patent_doc_number] => 20110263506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'PEPTIDES HAVING AN ACE INHIBITING EFFECT'
[patent_app_type] => utility
[patent_app_number] => 13/179078
[patent_app_country] => US
[patent_app_date] => 2011-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7628
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263506.pdf
[firstpage_image] =>[orig_patent_app_number] => 13179078
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/179078 | Peptides having an ACE inhibiting effect | Jul 7, 2011 | Issued |
Array
(
[id] => 8214255
[patent_doc_number] => 08193156
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2012-06-05
[patent_title] => 'Dipeptides incorporating selenoamino acids with enhanced bioavailability—synthesis, pharmaceutical and cosmeceutical applications thereof'
[patent_app_type] => utility
[patent_app_number] => 13/175016
[patent_app_country] => US
[patent_app_date] => 2011-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8842
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/193/08193156.pdf
[firstpage_image] =>[orig_patent_app_number] => 13175016
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/175016 | Dipeptides incorporating selenoamino acids with enhanced bioavailability—synthesis, pharmaceutical and cosmeceutical applications thereof | Jun 30, 2011 | Issued |
Array
(
[id] => 7754524
[patent_doc_number] => 20120027720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'PEPTIDE CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 13/168734
[patent_app_country] => US
[patent_app_date] => 2011-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16524
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20120027720.pdf
[firstpage_image] =>[orig_patent_app_number] => 13168734
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/168734 | PEPTIDE CONJUGATES | Jun 23, 2011 | Abandoned |
Array
(
[id] => 8265831
[patent_doc_number] => 20120165258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'Compositions and Methods for Treatment of Thrombosis and for Prolonging Survival of Stored Platelets'
[patent_app_type] => utility
[patent_app_number] => 13/168048
[patent_app_country] => US
[patent_app_date] => 2011-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13163
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13168048
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/168048 | Compositions and methods for treatment of thrombosis and for prolonging survival of stored platelets | Jun 23, 2011 | Issued |
Array
(
[id] => 7487782
[patent_doc_number] => 20110236547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'METHODS FOR SEPARATING PROTEINS FROM CONNECTIVE TISSUE'
[patent_app_type] => utility
[patent_app_number] => 13/151846
[patent_app_country] => US
[patent_app_date] => 2011-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11024
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20110236547.pdf
[firstpage_image] =>[orig_patent_app_number] => 13151846
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/151846 | Methods for separating proteins from connective tissue | Jun 1, 2011 | Issued |
Array
(
[id] => 9524304
[patent_doc_number] => 08748570
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-10
[patent_title] => 'Insulin analogues'
[patent_app_type] => utility
[patent_app_number] => 13/502085
[patent_app_country] => US
[patent_app_date] => 2011-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 82121
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502085
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/502085 | Insulin analogues | May 24, 2011 | Issued |
Array
(
[id] => 7502200
[patent_doc_number] => 20110263817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'METAL-BINDING COMPOUNDS AND USES THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 13/110550
[patent_app_country] => US
[patent_app_date] => 2011-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 31734
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263817.pdf
[firstpage_image] =>[orig_patent_app_number] => 13110550
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/110550 | METAL-BINDING COMPOUNDS AND USES THEREFOR | May 17, 2011 | Abandoned |
Array
(
[id] => 8489123
[patent_doc_number] => 20120288530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'TISSUE SEALANTS FROM PLASMA DERIVED PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/107375
[patent_app_country] => US
[patent_app_date] => 2011-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9327
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13107375
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/107375 | Tissue sealants from plasma derived proteins | May 12, 2011 | Issued |